{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:44:32Z","timestamp":1757623472660,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005258","name":"National Center for HIV\/AIDS Viral Hepatitis STD and TB Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["5NU38PS004644"],"award-info":[{"award-number":["5NU38PS004644"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI146555-02"],"award-info":[{"award-number":["R01AI146555-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jval.2025.03.009","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:39:15Z","timestamp":1744285155000},"page":"1029-1037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States"],"prefix":"10.1016","volume":"28","author":[{"given":"Nicole A.","family":"Swartwood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam B.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett R.","family":"Beeler Asay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles R.","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas A.","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jval.2025.03.009_bib3","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2019.19365","article-title":"Prevalence of diabetes by race and ethnicity in the United States, 2011-2016","volume":"322","author":"Cheng","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jval.2025.03.009_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.amepre.2019.12.010","article-title":"Tuberculosis infection among people with diabetes: United States population differences by race\/ethnicity","volume":"58","author":"Haddad","year":"2020","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.jval.2025.03.009_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/EDE.0000000000001707","article-title":"Latent TB reactivation rates for TB risk populations in the United States","volume":"35","author":"Ekramnia","year":"2024","journal-title":"Epidemiology"},{"issue":"7","key":"10.1016\/j.jval.2025.03.009_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"issue":"suppl 1","key":"10.1016\/j.jval.2025.03.009_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5588\/pha.13.0024","article-title":"Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review [Review article]","volume":"3","author":"Harries","year":"2013","journal-title":"Public Health Action"},{"year":"2023","series-title":"IPUMS USA: Version 13.0","author":"Ruggles","key":"10.1016\/j.jval.2025.03.009_bib9"},{"key":"10.1016\/j.jval.2025.03.009_bib11","series-title":"IPUMS Health Surveys: National Health Interview Survey, version 7.3","article-title":"Data","author":"Blewett","year":"2023"},{"issue":"suppl 1","key":"10.1016\/j.jval.2025.03.009_bib13","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jval.2025.03.009_bib14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/thoraxjnl-2018-211715","article-title":"Evaluating latent tuberculosis infection diagnostics using latent class analysis","volume":"73","author":"Stout","year":"2018","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.jval.2025.03.009_bib15","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/cid\/ciac248","article-title":"Evaluation of the latent tuberculosis care cascade among public health clinics in the United States","volume":"75","author":"Holzman","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.jval.2025.03.009_bib16","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jval.2025.03.009_bib18","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170219","article-title":"Deaths attributable to diabetes in the United States: comparison of data sources and estimation approaches","volume":"12","author":"Stokes","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12916-023-02785-y","article-title":"Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States","volume":"21","author":"Swartwood","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.jval.2025.03.009_bib21","article-title":"Model of interventions for tuberculosis in the United States (MITUS)","author":"Swartwood","year":"2024","journal-title":"GitHub"},{"author":"Wilmoth","key":"10.1016\/j.jval.2025.03.009_bib22"},{"issue":"Suppl 1","key":"10.1016\/j.jval.2025.03.009_bib23","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","article-title":"QALYs: the basics","volume":"12","author":"Weinstein","year":"2009","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2025.03.009_bib24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0272989X08315240","article-title":"Systematic review: health-state utilities in liver disease: a systematic review","volume":"28","author":"McLernon","year":"2008","journal-title":"Med Decis Mak"},{"issue":"12","key":"10.1016\/j.jval.2025.03.009_bib25","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.5588\/ijtld.13.0423","article-title":"Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States","volume":"17","author":"Shepardson","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.jval.2025.03.009_bib26","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11136-014-0858-6","article-title":"The impact of tuberculosis on health utility: a longitudinal cohort study","volume":"24","author":"Bauer","year":"2015","journal-title":"Qual Life Res"},{"issue":"10","key":"10.1016\/j.jval.2025.03.009_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jval.2025.03.009_bib29","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.3201\/eid2910.230314","article-title":"Estimated costs of 4-month pulmonary tuberculosis treatment regimen, United States","volume":"29","author":"Winston","year":"2023","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.jval.2025.03.009_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5588\/ijtld.23.0621","article-title":"Estimated treatment costs for multidrug-resistant TB in the United States","volume":"28","author":"Marks","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"author":"Jiao","key":"10.1016\/j.jval.2025.03.009_bib31"},{"issue":"11","key":"10.1016\/j.jval.2025.03.009_bib33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-8587(22)00252-2","article-title":"Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study","volume":"10","author":"Tomic","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1016\/j.jval.2025.03.009_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/13696998.2018.1542520","article-title":"Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations","volume":"22","author":"Grosse","year":"2019","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib35","first-page":"3","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"7","author":"Husereau","year":"2022","journal-title":"MDM Policy Pract"},{"year":"2016","series-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","key":"10.1016\/j.jval.2025.03.009_bib36"},{"year":"1997","series-title":"Monte Carlo Simulation","author":"Mooney","key":"10.1016\/j.jval.2025.03.009_bib37"},{"issue":"4","key":"10.1016\/j.jval.2025.03.009_bib38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1541-0420.2010.01399.x","article-title":"Estimating and projecting trends in HIV\/AIDS generalized epidemics using incremental mixture importance sampling","volume":"66","author":"Raftery","year":"2010","journal-title":"Biometrics"},{"year":"2016","series-title":"A Language and Environment for Statistical Computing","author":"Team","key":"10.1016\/j.jval.2025.03.009_bib39"},{"author":"Lumley","key":"10.1016\/j.jval.2025.03.009_bib40"},{"year":"2002","series-title":"Modern Applied Statistics With S","author":"Venables","key":"10.1016\/j.jval.2025.03.009_bib41"},{"issue":"8","key":"10.1016\/j.jval.2025.03.009_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i08","article-title":"Rcpp: seamless R and C++ integration","volume":"40","author":"Eddelbuettel","year":"2011","journal-title":"J Stat Softw"},{"issue":"4","key":"10.1016\/j.jval.2025.03.009_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249012","article-title":"State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity","volume":"16","author":"Mirzazadeh","year":"2021","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.jval.2025.03.009_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jama.2023.4899","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"329","author":"Mangione","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jval.2025.03.009_bib46","doi-asserted-by":"crossref","first-page":"e3476","DOI":"10.1093\/cid\/ciaa857","article-title":"Model-based cost-effectiveness of state-level latent tuberculosis interventions in California, Florida, New York, and Texas","volume":"73","author":"Jo","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jval.2025.03.009_bib47","first-page":"479","article-title":"Effectiveness and cost-effectiveness of expanded targeted testing and treatment of latent tuberculosis infection among the Medicare population in 2022","volume":"178","author":"Li","year":"2024"},{"issue":"12","key":"10.1016\/j.jval.2025.03.009_bib48","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model","volume":"177","author":"Tasillo","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5588\/ijtld.22.0654","article-title":"Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA","volume":"28","author":"Beeler Asay","year":"2024","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/tropicalmed6010008","article-title":"The interaction of diabetes and tuberculosis: translating research to policy and practice","volume":"6","author":"van Crevel","year":"2021","journal-title":"Trop Med Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.jval.2025.03.009_bib52","first-page":"S52","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142024","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jval.2025.03.009_bib53","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2337\/dci20-0017","article-title":"Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008?","volume":"43","author":"Siegel","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jval.2025.03.009_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140881","article-title":"RS, et al. Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011-2012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1478-7954-7-16","article-title":"Diabetes prevalence and diagnosis in US states: analysis of health surveys","volume":"7","author":"Danaei","year":"2009","journal-title":"Popul Health Metr"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40615-016-0335-8","article-title":"Racial\/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status","volume":"5","author":"Canedo","year":"2018","journal-title":"J Racial Ethn Health Disparities"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001275","article-title":"Diabetes mellitus among adults with tuberculosis in the USA, 2010-2017","volume":"8","author":"Armstrong","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib61","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41598-017-01767-4","article-title":"Systems immunology of diabetes-tuberculosis comorbidity reveals signatures of disease complications","volume":"7","author":"Prada-Medina","year":"2017","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jval.2025.03.009_bib62","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.5588\/ijtld.18.0045","article-title":"Convergence of non-communicable diseases and tuberculosis: a two-way street?","volume":"22","author":"Magee","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.jval.2025.03.009_bib63","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2213-8587(14)70109-3","article-title":"Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice","volume":"2","author":"L\u00f6nnroth","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.jval.2025.03.009_bib64","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12879-019-4548-4","article-title":"Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review","volume":"19","author":"Yu","year":"2019","journal-title":"BMC Infect Dis"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525019655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525019655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:10:22Z","timestamp":1757401822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525019655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1098301525019655"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.03.009","relation":{},"ISSN":["1098-3015"],"issn-type":[{"type":"print","value":"1098-3015"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}